Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1951 1
1966 1
1968 1
1973 3
1974 4
1975 3
1976 2
1977 1
1978 3
1979 2
1982 2
1983 4
1984 2
1985 2
1986 3
1987 2
1988 10
1989 3
1990 3
1991 8
1992 5
1993 8
1994 3
1995 4
1996 2
1997 5
1998 6
1999 2
2000 1
2001 4
2002 5
2003 5
2004 7
2005 5
2006 6
2007 6
2008 10
2009 11
2010 17
2011 19
2012 25
2013 17
2014 19
2015 14
2016 9
2017 8
2018 12
2019 4
2020 14
2021 22
2022 23
2023 15
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

343 results

Results by year

Filters applied: . Clear all
Page 1
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.
Brahmer JR, Lee JS, Ciuleanu TE, Bernabe Caro R, Nishio M, Urban L, Audigier-Valette C, Lupinacci L, Sangha R, Pluzanski A, Burgers J, Mahave M, Ahmed S, Schoenfeld AJ, Paz-Ares LG, Reck M, Borghaei H, O'Byrne KJ, Gupta RG, Bushong J, Li L, Blum SI, Eccles LJ, Ramalingam SS. Brahmer JR, et al. Among authors: burgers j. J Clin Oncol. 2023 Feb 20;41(6):1200-1212. doi: 10.1200/JCO.22.01503. Epub 2022 Oct 12. J Clin Oncol. 2023. PMID: 36223558 Free PMC article. Clinical Trial.
AGREE II: advancing guideline development, reporting and evaluation in health care.
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium. Brouwers MC, et al. Among authors: burgers js. CMAJ. 2010 Dec 14;182(18):E839-42. doi: 10.1503/cmaj.090449. Epub 2010 Jul 5. CMAJ. 2010. PMID: 20603348 Free PMC article. Review. No abstract available.
First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial.
Paz-Ares LG, Ramalingam SS, Ciuleanu TE, Lee JS, Urban L, Caro RB, Park K, Sakai H, Ohe Y, Nishio M, Audigier-Valette C, Burgers JA, Pluzanski A, Sangha R, Gallardo C, Takeda M, Linardou H, Lupinacci L, Lee KH, Caserta C, Provencio M, Carcereny E, Otterson GA, Schenker M, Zurawski B, Alexandru A, Vergnenegre A, Raimbourg J, Feeney K, Kim SW, Borghaei H, O'Byrne KJ, Hellmann MD, Memaj A, Nathan FE, Bushong J, Tran P, Brahmer JR, Reck M. Paz-Ares LG, et al. Among authors: burgers ja. J Thorac Oncol. 2022 Feb;17(2):289-308. doi: 10.1016/j.jtho.2021.09.010. Epub 2021 Oct 12. J Thorac Oncol. 2022. PMID: 34648948 Free article. Clinical Trial.
Samen sterk door persoonsgerichte en digitale zorg.
Boudewijns E, Gidding-Slok A, Burgers J. Boudewijns E, et al. Among authors: burgers j. Huisarts Wet. 2022;65(4):14-18. doi: 10.1007/s12445-022-1423-0. Epub 2022 Mar 14. Huisarts Wet. 2022. PMID: 35309971 Free PMC article. Dutch.
Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1.
Reck M, Ciuleanu TE, Lee JS, Schenker M, Zurawski B, Kim SW, Mahave M, Alexandru A, Peters S, Pluzanski A, Caro RB, Linardou H, Burgers JA, Nishio M, Martinez-Marti A, Azuma K, Axelrod R, Paz-Ares LG, Ramalingam SS, Borghaei H, O'Byrne KJ, Li L, Bushong J, Gupta RG, Grootendorst DJ, Eccles LJ, Brahmer JR. Reck M, et al. Among authors: burgers ja. J Thorac Oncol. 2023 Aug;18(8):1055-1069. doi: 10.1016/j.jtho.2023.04.021. Epub 2023 May 3. J Thorac Oncol. 2023. PMID: 37146754 Free article. Clinical Trial.
Endobronchial ultrasound.
Burgers JA, Herth F, Becker HD. Burgers JA, et al. Lung Cancer. 2001 Dec;34 Suppl 2:S109-13. doi: 10.1016/s0169-5002(01)00349-x. Lung Cancer. 2001. PMID: 11720750 Review.
Current chemotherapy strategies in malignant pleural mesothelioma.
de Gooijer CJ, Baas P, Burgers JA. de Gooijer CJ, et al. Among authors: burgers ja. Transl Lung Cancer Res. 2018 Oct;7(5):574-583. doi: 10.21037/tlcr.2018.04.10. Transl Lung Cancer Res. 2018. PMID: 30450296 Free PMC article. Review.
Dose-dependent pharmacokinetics.
van Rossum JM, van Lingen G, Burgers JP. van Rossum JM, et al. Among authors: burgers jp. Pharmacol Ther. 1983;21(1):77-99. doi: 10.1016/0163-7258(83)90068-2. Pharmacol Ther. 1983. PMID: 6353440 Review. No abstract available.
Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study.
Douma LH, Lalezari F, van der Noort V, de Vries JF, Monkhorst K, Smesseim I, Baas P, Schilder B, Vermeulen M, Burgers JA, de Gooijer CJ. Douma LH, et al. Among authors: burgers ja. Lancet Oncol. 2023 Nov;24(11):1219-1228. doi: 10.1016/S1470-2045(23)00446-1. Epub 2023 Oct 13. Lancet Oncol. 2023. PMID: 37844598 Clinical Trial.
[Polypharmacy in elderly patients].
van Marum RJ, Burgers JS, Bouvy ML. van Marum RJ, et al. Among authors: burgers js. Ned Tijdschr Geneeskd. 2021 Jun 17;165:D5184. Ned Tijdschr Geneeskd. 2021. PMID: 34346572 Dutch.
343 results